| Functional classification and experimental dissection of long noncoding RNAs F Kopp, JT Mendell Cell 172 (3), 393-407, 2018 | 2967 | 2018 |
| Noncoding RNA NORAD regulates genomic stability by sequestering PUMILIO proteins S Lee, F Kopp, TC Chang, A Sataluri, B Chen, S Sivakumar, H Yu, Y Xie, ... Cell 164 (1), 69-80, 2016 | 845 | 2016 |
| An Argonaute phosphorylation cycle promotes microRNA-mediated silencing RJ Golden, B Chen, T Li, J Braun, H Manjunath, X Chen, J Wu, V Schmid, ... Nature 542 (7640), 197-202, 2017 | 256 | 2017 |
| miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression F Kopp, PS Oak, E Wagner, A Roidl PloS one 7 (11), e50469, 2012 | 154 | 2012 |
| Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2‐positive cancer cells and cancer stem cells PS Oak, F Kopp, C Thakur, JW Ellwart, UR Rapp, A Ullrich, E Wagner, ... International journal of cancer 131 (12), 2808-2819, 2012 | 97 | 2012 |
| PUMILIO hyperactivity drives premature aging of Norad-deficient mice F Kopp, MM Elguindy, ME Yalvac, H Zhang, B Chen, FA Gillett, S Lee, ... Elife 8, e42650, 2019 | 91 | 2019 |
| The proto-oncogene KRAS is targeted by miR-200c F Kopp, E Wagner, A Roidl Oncotarget 5 (1), 185, 2014 | 88 | 2014 |
| PUMILIO, but not RBMX, binding is required for regulation of genomic stability by noncoding RNA NORAD MM Elguindy, F Kopp, M Goodarzi, F Rehfeld, A Thomas, TC Chang, ... Elife 8, e48625, 2019 | 75 | 2019 |
| Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration F Kopp, A Hermawan, PS Oak, A Herrmann, E Wagner, A Roidl Molecular cancer 13 (1), 16, 2014 | 70 | 2014 |
| Molecular functions and biological roles of long non‐coding RNAs in human physiology and disease F Kopp The journal of gene medicine 21 (8), e3104, 2019 | 52 | 2019 |
| Generation of a tumor-and tissue-specific episomal non-viral vector system R Haase, T Magnusson, B Su, F Kopp, E Wagner, H Lipps, A Baiker, ... BMC biotechnology 13 (1), 1-11, 2013 | 24 | 2013 |
| Sequential salinomycin treatment results in resistance formation through clonal selection of epithelial-like tumor cells F Kopp, A Hermawan, PS Oak, VK Ulaganathan, A Herrmann, N Elnikhely, ... Translational oncology 7 (6), 702-711, 2014 | 20 | 2014 |
| De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells F Kopp, M Schnoedt, R Haase, E Wagner, A Roidl, M Ogris Gene therapy 20 (11), 1104-1109, 2013 | 11 | 2013 |
| Structure-based peptide ligand design for improved epidermal growth factor receptor targeted gene delivery S Decker, A Taschauer, E Geppl, V Pirhofer, M Schauer, S Pöschl, F Kopp, ... European Journal of Pharmaceutics and Biopharmaceutics 176, 211-221, 2022 | 4 | 2022 |
| Long noncoding RNAs as versatile molecular regulators of cellular stress response and homeostasis J Scholda, TTA Nguyen, F Kopp Human Genetics, 1-17, 2023 | 3 | 2023 |
| 175: miR-27a is a functional biomarker for tamoxifen treatment of luminal A/B breast tumors B Ljepoja, J Garcia-Roman, F Kopp, E Wagner, A Roidl European Journal of Cancer, S39, 2014 | | 2014 |
| Novel insights into the role of microRNAs in chemoresistance, tumor progression and cancer therapy F Kopp lmu, 2013 | | 2013 |
| Generation of a tumor-and tissue-specific episomal non-viral vector system M Ogris, A Baiker, H Lipps, E Wagner, F Kopp, B Su, T Magnusson, ... | | 2013 |
| Nonviral gene delivery to melanoma combining selective cellular uptake and tumour-specific transcription J Viola, P Grayeski, S Graf, F Kopp, E Wagner, R Besch, M Ogris HUMAN GENE THERAPY 23 (10), A146-A146, 2012 | | 2012 |
